Cell-Based Assays: Technologies and Global Markets
Report Scope:
This report is an update of an earlier report of the same title. This report offers a comprehensive analysis of the global cell-based assays market. Segmentation is based on product, type/application and end user. Based on type/application, the market is segmented as drug discovery for validating drug targets/lead profiling assays, absorption, distribution, metabolism, and excretion (ADME) toxicity assays and basic research. The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
The report provides a detailed overview and analysis of the present and future global market for cell-based assay techniques. The report analyzes in detail currently available cell-based assays and their markets. Industry growth drivers, restraints and opportunities are also discussed in detail. The report also provides information on competitive landscape, elaborative company profiles and the impact of COVID-19 on the market.
Report Includes:
- - 63 tables
- An up-to-date review of the global markets for cell-based assays and related technologies
- Analyses of the global market trends, with historic sales data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future potential in the market for cell-based assays, and areas of focus to forecast this market into various segments and sub-segments
- Estimation of the actual market size for cell-based assays, revenue forecast, and corresponding market share analysis based on product, type/application, end user and geographic region
- Market assessment of the cell-based assays available and currently being used, new developments, spending trends, and revenue prospects for cell-based assays in the pharmaceutical industry
- Coverage of major issues involved in the research and development (R&D) of more effective cell-based approaches for drug discovery
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
- Competitive analysis of the market for cell-based assays and updated information on the mergers, acquisitions, collaborations and recent developments during the 2020-2022 period
- Descriptive company profiles of the leading global players, including Becton, Dickinson & Company, Charles River Laboratories, General Electric Healthcare, Merck KGaA and Thermo Fisher Scientific Inc.Agilent Technologies Inc.
Becton, Dickinson & Co.
Bio-rad Laboratories
Bioivt
Cell Biolabs Inc.
Cell Biologics
Cell Signaling Technology Inc.
Charles River
Corning, Inc.
Danaher
Discoverx Corp.
Enzo Life Sciences
Evotec Ag
Fujifilm Cellular Dynamics Inc. (Fcdi)
Ge Healthcare
Lonza
Merck Kgaa
Oncolmmunin
Perkinelmer
Promega Corp.
Thermo Fisher Scientific
- Chapter 1 Introduction
- Study Goals And Objectives
- Reasons For Doing This Study
- What's New In This Update?
- Scope Of Report
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Bcc Custom Research
- Related Bcc Research Reports
- Chapter 2 Summary And Highlights
- Chapter 3 Overview
- Introduction
- Overview: Cell-based Assays
- Drug Discovery
- Tools For Drug Discovery
- High-content Screening
- High-content Screening Products
- Data Analysis
- Cell-based Screening
- Proliferation Assays
- Apoptosis Assays
- Activation Assays
- Assays To Measure Gene Expression
- Proof Of Concept For Cell-based Assays
- Cell-based Assays And Technology Trends
- Advancements In Cell-based Assays
- Novel Cell-based Assay Using Organoids, Scaffolds/Hydrogels And Organs-on-a-chip
- Spheroids For Drug Development
- Label-free Cell-based Assay Technology Using Biolayer Interferometry
- Lineage Sequencing For Mutational Analysis And Cancer-based Studies
- Evaluation Of Hantavirus Replication Using In-cell Western Assay
- Quantitative Cell-based Assay Using A High-content Analysis Platform
- High-throughput Single-cell Transcriptome Sequencing
- Ex Vivo Chemosensitivity Assays For Individualized Cancer Chemotherapy
- Luciferase-based High-throughput Screening Assay
- Functionally Relevant Morphological Profiling For Mesenchymal Stromal Cells
- G Protein-coupled Receptors
- Gpcrs: A Potent Class Of Drug Targets
- Gpcr Drugs
- Developments
- Cell-based Assays: Screening Ion Channels
- Chapter 4 Assays For Drug Discovery
- Cell-based Approaches For Adme/Tox Screening
- Market Opportunities
- Adme And Toxicity Screening
- Multiplexed Cell-based Assays
- High-throughput Imaging-based Platform For Cell-based Assays
- Cell Assays In Today's Drug Discovery Process
- Label-free Cellular Assays: The Relevant Future Of Drug Discovery
- Conclusion
- Chapter 5 Cell-based Assays: Current Technologies
- Factors In Cell-based Assay Development
- Reporter Gene Technology
- Cell-based Assays For Studying Protein-protein Interactions
- Cell-based Protein-fragment Complementation Assays
- Measuring Calcium Signaling
- Cell-based Label-free Approaches
- Label-free Detection
- Companies
- Thermo Fisher
- Cellsensor
- Lanthascreen
- Molecular Devices
- Automation And Miniaturization
- Cell Patterning
- Cell-based Assays And Physiological Relevance
- Cell-based Assays And Multiplexing
- Developing Reporter Assays
- Reporter Assays And Multiplexing
- Ultrahigh-throughput Screening
- Development Of The Pathhunter Assay
- High-content Screening Technology
- Imaging Cells For Cell-based Assays
- Microscopic Visualization Of Cells
- Quantum Dots
- Label-free Imaging
- Investigational New Studies In Drug Development
- Role Of Adme In Drug Design
- Prodrug Strategies
- Molecular Modeling
- Summary
- Limitations Of Cell-based Assays In The Risk Assessment Process
- Bottlenecks In Cell-based Screening
- Methods To Improve Throughput In Cell-based Assays
- New Technologies
- Datachip
- Bind Technology
- Miniaturization Of Biological Assays
- Microfluidic Cell Culture Systems For Drug Research
- Conclusion
- Chapter 6 Commercialization Of Cell-based Assays
- Role Of Cell-based Assays
- Demand For Cell-based Assays
- Drug Discovery And Cell-based Assays
- Opportunities For Market Adoption
- Measuring Cell Proliferation
- Companies Offering Cell Proliferation Assays
- Move Toward Therapies With Stem And Immune Cells
- Cell-based Screening Assays
- Orphan Receptors
- Summary
- Chapter 7 Market Dynamics
- Factors Affecting The Market For Cell-based Assays
- Market Drivers
- Market Restraints
- Chapter 8 Impact Of Covid-19
- Introduction
- Outbreak
- Covid-19 Symptoms
- Progression Of Covid-19
- Incubation Period
- Epidemiology
- Collaboration Between Organizations And Governments
- Spread Of Disease
- Impact Of Covid-19 On The Cell-based Assay Market
- Chapter 9 Global Market For Cell-based Assays By Application
- Current Market Overview
- Cell-based Assays
- Market For Cell-based Assays
- Applications
- Drug Discovery
- Basic Research
- Adme And Toxicology
- Chapter 10 Global Market For Cell-based Assays By Segment
- Consumables
- Instruments
- Software
- Services
- Chapter 11 Cell-based Assays Market By End User
- Biotechnology And Pharmaceutical Companies
- Academic And Research Institutes
- Contract Research Organizations
- Chapter 12 Global Market For Cell-based Assays By Region
- Global Market Overview
- Regional Markets
- North America
- Europe
- Asia-pacific
- Rest Of The World (Row)
- Chapter 13 Competitive Landscape
- Mergers, Acquisitions, And Collaborations
- Recent Developments
- Competitive Analysis
- Chapter 14 Company Profiles
- Agilent Technologies Inc.
- Becton, Dickinson & Co.
- Bioivt
- Bio-rad Laboratories
- Cell Biologics
- Cell Biolabs Inc.
- Cell Signaling Technology Inc.
- Charles River
- Corning, Inc.
- Danaher
- Discoverx Corp.
- Enzo Life Sciences
- Evotec Ag
- Fujifilm Cellular Dynamics Inc. (Fcdi)
- Ge Healthcare
- Lonza
- Merck Kgaa
- Oncolmmunin
- Perkinelmer
- Promega Corp.
- Thermo Fisher Scientific
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook